A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6.
Shen, Y., Li, F., Szewczyk, M.M., Halabelian, L., Chau, I., Eram, M.S., Dela Sena, C., Park, K.S., Meng, F., Chen, H., Zeng, H., Dong, A., Wu, H., Trush, V.V., McLeod, D., Zepeda-Velazquez, C.A., Campbell, R.M., Mader, M.M., Watson, B.M., Schapira, M., Arrowsmith, C.H., Al-Awar, R., Barsyte-Lovejoy, D., Kaniskan, H.U., Brown, P.J., Vedadi, M., Jin, J.(2021) J Med Chem 64: 3697-3706
- PubMed: 33591753 
- DOI: 10.1021/acs.jmedchem.0c02160
- Primary Citation of Related Structures:  
6W6D - PubMed Abstract: 
Protein arginine methyltransferase 6 (PRMT6) catalyzes monomethylation and asymmetric dimethylation of arginine residues in various proteins, plays important roles in biological processes, and is associated with multiple cancers. To date, a highly selective PRMT6 inhibitor has not been reported ...